Brittany Hively News


Emails show McKesson employees felt 'overwhelmed,' 'not possible to be truly diligent'

By Brittany Hively |
CHARLESTON – As the landmark federal opioid trial entered its fourth week, plaintiffs jumped into McKesson Corporation’s threshold guidelines and due diligence process.

At opioid trial, drug distributors continue to push blame toward DEA

By Brittany Hively |
CHARLESTON – As the landmark federal opioid trial nears the end of its third week, testimony focused on Cardinal Health’s acknowledgement and regulations related to excessive controlled substance ordering.

Lawyers continue to question company's knowledge of excessive opioid shipments

By Brittany Hively |
CHARLESTON – As the landmark opioid trial continues, lawyers brought in a former AmerisourceBergen’s sales executive to ask what he knew about more than 32 million prescription pain pills being shipped to Huntington and the rest of Cabell County over an eight-year span.

Opioid data: Threshold kept increasing as Huntington/Cabell received more than 36.2M doses in 8 years

By Brittany Hively |
CHARLESTON – As the federal trial against three major opioid distributors continued, data showing pharmacies in Huntington and Cabell County were ordering well above the national average of controlled substances, some ordering more than five times the national average.

Distributor says it did more than necessary to abate suspicious opioid orders

By Brittany Hively |
CHARLESTON — As the landmark federal opioid trial entered its third week, testimony focused on two AmerisourceBergen employees who oversaw regulations involving diversion control.